Skip to main content
Signal8

Cann American Corp. (CNNA)

Cann American Corp. is an early-stage enterprise dedicated to developing specialized Cannabis sativa varieties designed for animal consumption. The company's strategic focus is on markets within various European Union countries. Established in 2004 and headquartered in Cloverdale, California, Cann American Corp. previously operated as Canamed4Pets, Inc. before officially rebranding in December 2019.

Sector: Drug Manufacturers - Specialty & Generic

Industry: Drug Manufacturers - Specialty & Generic

Cann American Corp. logo

Cann American Corp.

OTC:CNNAHealthcare
+25.00%$0.0050
CLOSED
Mkt Cap$3.69M
EV$3.69M
Float377.22M
O/S737.84M
VOL108K sh
$ Vol$270
RVOL0.82×
Inst Own-
SI0.1%
Net Cash/Sh-$0.00
Dilution
Cann American Corp. logoOTC:CNNAClosed$0.0050+25.00%
Financials Summary
Revenue$0
Net Income$4K
Total Assets$65
Free Cash Flow$5
Debt & Equity
Total Debt$359
Total Equity-$3K
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:10Reverse split
    Nov 13, 202010 shares → 1
Balance Sheet Details
Assets$65
Liabilities$3K
Accounts Receivable$0
Accounts Payable$0
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2022FY 2021FY 2019FY 2018FY 2017FY 2011FY 2010FY 2009FY 2008FY 2007
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2023-02-282022-02-282020-02-282019-02-282018-02-282012-02-282011-02-282010-02-282009-02-282008-02-28
Revenue$0$0$26$117$26$0$0$0$0$0
YoY Growth---77.6%355.3%------
Cost of Revenue$0$0$9$29$6$0$0$0$0$0
Gross Profit$0$0$17$88$20$0$0$0$0$0
Gross Margin--64.0%75.0%78.4%-----
Research and Development$0$0$0$0$0$0$500$500$8K$0
Selling, General, and Administrative$146$199$25$91$20$258K$45K$12K$39K$12K
Other$0$0$242$0$0$0$0$0$0$0
Total Operating Expenses$146$199$267$95$21$258K$45K$12K$47K$12K
Operating Income (EBIT)-$145-$198-$14-$7-$1-$258K-$45K-$12K-$47K-$12K
Operating Margin---54.0%-6.4%-2.0%-----
Interest Expense$0$0$0$0$0$7K$135$115$158$152
Interest Income$0$4K$0$0$0$0$0$0$0$0
Other Income (Expense)$4K$11K-$235$0$0-$1.39M$0$0$0$0
Income Before Tax (EBT)$4K$11K-$249-$7-$1-$258K$0$0$0$0
Income Tax Expense$0$0$0$0$0$7K$45K$12K$47K$12K
Net Income$4K$11K-$249-$7-$1-$265K-$45K-$12K-$47K-$12K
Net Income Margin---954.0%-6.4%-2.0%-----
Supplementary Data
EPS0.010.04-0.00-0.00-0.00-109.74-14.34-3.83-20.87-3.01
Diluted EPS0.010.04-0.00-0.00-0.00-109.74-14.34-3.83-20.87-3.01
Weighted Average OS310,000235,000531,494898,188898,1882,4113,1643,2522,2373,962
EBITDA-$114$1-$8-$3$0-$1.64M-$45K-$12K-$47K-$12K
EBITDA Margin---31.0%-3.0%0.6%-----
Balance Sheet
PeriodFY 2022FY 2021FY 2019FY 2018FY 2017FY 2011FY 2010FY 2009FY 2008FY 2007
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2023-02-282022-02-282020-02-282019-02-282018-02-282012-02-282011-02-282010-02-282009-02-282008-02-28
Assets
Current Assets
Cash and Cash Equivalents$11$0$46$2$2$191$59$96$37$5K
Short-Term Investments$38$200$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$48$201$46$2$2$191$59$96$37$5K
Accounts Receivable$0$0$0$0$0$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$0$0$0
Other Current Assets$17$5$0$0$0$0$0$0$0$0
Total Current Assets$65$206$46$2$2$191$10K$96$37$5K
Long-Term Assets
Property, Plant & Equipment Net$0$0$1$7$11$0$0$0$0$0
Goodwill$0$0$0$186$186$0$0$0$0$0
Intangible Assets$0$0$0$0$0$1.19M$1.19M$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$0$0$0$0$0
Total Long-Term Assets$0$0$1$193$197$1.19M$1.19M$0$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0
Total Assets$65$206$47$195$199$1.19M$1.2M$96$37$5K
Liabilities
Current Liabilities
Accounts Payable$0$0$2$3$0$202K$8K$3K$0$5K
Short-Term Debt$359$402$2$200$0$72K$0$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$0$0$0
Other Current Liabilities$3K$6K$0$0$0-$43K$0$0$0$0
Total Current Liabilities$3K$7K$4$203$0$244K$8K$14$1K$5K
Long-Term Liabilities
Long-Term Debt$0$0$0$0$200$0$61K$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$0$0$0$0$200$0$61K$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0
Total Liabilities$3K$7K$4$203$200$244K$69K$14K$1K$5K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0
Common Stock$947$933$899$898$898$9K$9K$13K$13K$761
Retained Earnings-$8K-$12K-$5K-$5K-$5K-$399K-$135K-$89K-$77K-$30K
Comprehensive Income & Other$0$0-$0$0$0$0$0$0$0$0
Other Stockholders' Equity$5K$5K$4K$4K$4K$1.34M$1.26M$63K$63K$29K
Total Equity-$3K-$7K$43-$8-$1$948K$1.13M-$13K-$963-$276
Minority Interest$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$65$206$47$195$199$1.19M$1.2M$96$37$5K
Supplementary Data
Total Debt$359$402$2$200$200$65K$61K$0$0$0
Net Debt$349$402-$44$198$198$64K$60K-$96-$37-$5K
Cash Flow Statement
PeriodFY 2022FY 2021FY 2019FY 2018FY 2017FY 2011FY 2010FY 2009FY 2008FY 2007
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2023-02-282022-02-282020-02-282019-02-282018-02-282012-02-282011-02-282010-02-282009-02-282008-02-28
Operating Activities
Net Income$4K$11K-$249-$7-$1$0$0$0$0$0
Depreciation & Amortization$31$199$6$4$1$0$0$0$0$0
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$0$0$0$0$0$30K$0$0$0$0
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$0$0$0$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$0$0$0$0$0$0$0$0$0$0
  Other Working Capital$151-$85$0$0$0$0$0$0$0$0
Total Working Capital Change$151-$85$0$0$0$181K-$5K$3K-$5K$5K
Other Non-Cash Items-$4K-$11K-$1$3$0-$265K-$45K-$12K-$39K-$12K
Net Cash from Operating$5-$342-$244-$1$0-$54K-$50K-$9K-$44K-$7K
Investing Activities
Capital Expenditures$0$0$0$0-$12$0-$500-$500-$8K$0
Acquisitions$0$0$0$0-$2$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$236$0-$186$0$0$0$0$0
Net Cash from Investing$0$0$236$0-$200$0-$500-$500-$8K$0
Financing Activities
Debt Repaid-----$200--$61K--$1K-
Common Stock Issuance$0$0$0$0$0$50K$0$0$46K$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$5$275$53$0$0-$11K$0$10K$0$0
Net Cash from Financing$5$275$53$0$200$54K$50K$10K$47K$0
Forex Effect$0$0$0$0$0$0$0$0$0$0
Net Change in Cash$10-$68$44-$1$0$132-$37$59-$5K-$7K
Supplementary Data
Operating Cash Flow$5-$342-$244-$1$0-$54K-$50K-$9K-$44K-$7K
Capital Expenditure$0$0$0$0-$12$0-$500-$500-$8K$0
Free Cash Flow$5-$342-$244-$1-$12-$54K-$50K-$9K-$52K-$7K
Cash at Beginning$0$68$0$2$2$59$96$37$5K$12K
Cash at End$11$0$46$2$2$191$59$96$37$5K